Globally Renowned Dermatologist and Sesderma Founder Professor Dr. Gabriel Serrano to Visit India to Showcase Cutting-Edge Derma-Tech for Indian Skincare at Scientific Symposiums Hosted by Iberia Pharmaceuticals
The exclusive dermo-focused symposiums will feature the latest advances in regenerative dermatology, nanotechnology, and science-backed skincare
Sesderma Founder and renowned Spanish dermatologist Professor Dr. Gabriel Serrano is visiting India to participate in exclusive scientific symposiums hosted by Iberia Pharmaceuticals. The symposiums, scheduled to take place in New Delhi and Hyderabad, will bring together the country’s dermatology community for meaningful discussions and an exchange of scientific knowledge and insights.
The ‘Grand Dermatology Symposiums’will bring together pharma skincare industry stakeholders including leading dermatologists, and key opinion leaders to explore the latest advancements in dermatological science and innovation.At the symposiums, Professor Dr. Gabriel Serrano will share insights into the regenerative dermatology, nanotechnology-based dermo-cosmetics, micro-needling technologies, skin longevity, healthy skin ageing and chemical peels tailored to the Indian skin photo types. The symposiums will focus on key global advancements in:
Professor Dr. Serrano will discuss emerging approaches to skin and body regeneration, including the growing role of regenerative medicine in skincare. He will also highlight innovative technologies and devices designed to enable more precise and effective skin treatments. Explaining the advanced skin peels, he will share his insights how they are developed to address the specific needs of Indian skin.
Widely known for being the pioneer in the application of nanotechnology in dermatology and for developing specialized skincare and cosmetic solutions, Professor Dr. Gabriel Serrano brings decades of expertise to these discussions. He holds several patents in anti-ageing skincare, chemical peels and sun-damage repair. He founded Sesderma with a vision to provide advance personalized, high-quality dermo-cosmetic solutions through research and innovation. Currently, he focuses on expanding Sesderma’s presence internationally, with the brand now available in more than 80 countries.
Speaking on his upcoming visit to India, Professor Dr. Gabriel Serrano says“I have always been committed to innovation and research, and I firmly believe that continuing to develop effective products and treatments is the only way to deliver the best. India’s dynamic skin profiles with growing demand for science-backed skincare makes for an exciting chapter ahead. The symposiums will provide an inspiring opportunity to collaborate with the dermatologist communities in India. I look forward to engaging with India’s medical community and sharing the latest developments in regenerative medicine, nanotechnology, and personalized skincare.”
As India’s dermatology and dermo- cosmetic sector is experiencing positive and a welcome shift towards evidence-based, and science-backed solutions for skincare, Sesderma, a global dermatology company, is growing its presence in India through increased engagement with India’s dermatology community, and continued investments in research & innovations for the Indian skin.
On the partnership with Sesderma, Mr. Nitin Jain, Founder and Managing Director, Iberia Pharmaceuticals, says, “The Indian youth is increasingly seeking skin care products backed by science-based formulations, and we at Iberia firmly believe that bringing world-class skincare solutions to India is key to this new wave of demand. Our partnership with Sesderma is built on a shared commitment to scientific excellence, innovation, and delivering advanced derma-tech in India.”
Iberia Pharmaceuticals being the official and exclusive partner for Sesderma in India, plays a significant role in boosting the brand’s growth in the country, and with its strong penetration in dermatology ecosystem, the market knowledge, and nationwide distribution capabilities, the company is leading the expansion of Sesderma across evolving markets including the Tier-II cities in India.
Commenting on the symposiums, Mr. Saurav Ojha, Co-Founder & Whole-Time Director at Iberia Pharmaceuticals says “At Iberia Pharmaceuticals, our aim has primarily been to bring the best of global dermatological science-backed skincare to India that addresses the unique needs of the Indian skin. The symposiums hosted by us for the celebrated Professor Dr. Gabriel Serrano provides a powerful knowledge exchange platform to India’s dermatological community.”
India’s increasing demand for science backed skincare, and deeper adoption of clinically certified dermo-cosmetic solutions, we are expanding our footprint beyond metropolitan markets to Tier-II cities, making advanced skincare innovations more accessible to people nationwide.